Global GLP-1 Peptide Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Glucagon-likepeptide-1 (GLP-1) is a hormone secreted by intestinal L cells. Its receptor (GLP-1R) is widely distributed in the central nervous system, cardiovascular system, muscles, and gastrointestinal tract. multiple organs and tissues. GLP-1 has glucose concentration-dependent hypoglycemic effects, and its receptor agonist (GLP-1RA) can simulate the physiological effects of GLP-1 and is an important drug for the treatment of diabetes and obesity. In addition, GLP-1RA also has protective effects on the cardiovascular system, kidneys, central nervous system, etc.
GLP-1 peptide drugs are often used to treat patients with type 2 diabetes. They can control blood sugar while also bringing weight loss and reducing cardiovascular risk.
The global GLP-1 Peptide Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “GLP-1 Peptide Drugs Industry Forecast” looks at past sales and reviews total world GLP-1 Peptide Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected GLP-1 Peptide Drugs sales for 2023 through 2029. With GLP-1 Peptide Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Peptide Drugs industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Peptide Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GLP-1 Peptide Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Peptide Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Peptide Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Peptide Drugs.
United States market for GLP-1 Peptide Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for GLP-1 Peptide Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for GLP-1 Peptide Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key GLP-1 Peptide Drugs players cover AstraZeneca, Novo Nordisk, Sanofi, GSK, Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Peptide Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Glucagon-likepeptide-1 (GLP-1) is a hormone secreted by intestinal L cells. Its receptor (GLP-1R) is widely distributed in the central nervous system, cardiovascular system, muscles, and gastrointestinal tract. multiple organs and tissues. GLP-1 has glucose concentration-dependent hypoglycemic effects, and its receptor agonist (GLP-1RA) can simulate the physiological effects of GLP-1 and is an important drug for the treatment of diabetes and obesity. In addition, GLP-1RA also has protective effects on the cardiovascular system, kidneys, central nervous system, etc.
GLP-1 peptide drugs are often used to treat patients with type 2 diabetes. They can control blood sugar while also bringing weight loss and reducing cardiovascular risk.
The global GLP-1 Peptide Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “GLP-1 Peptide Drugs Industry Forecast” looks at past sales and reviews total world GLP-1 Peptide Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected GLP-1 Peptide Drugs sales for 2023 through 2029. With GLP-1 Peptide Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Peptide Drugs industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Peptide Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GLP-1 Peptide Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Peptide Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Peptide Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Peptide Drugs.
United States market for GLP-1 Peptide Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for GLP-1 Peptide Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for GLP-1 Peptide Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key GLP-1 Peptide Drugs players cover AstraZeneca, Novo Nordisk, Sanofi, GSK, Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Peptide Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Injection
- Oral
- Type 2 Diabetes
- Obesity
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Injection
- Oral
- Type 2 Diabetes
- Obesity
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Novo Nordisk
- Sanofi
- GSK
- Eli Lilly
- Benemae Pharmaceutical
- Hansoh Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Peptide Drugs Market Size 2019-2030
2.1.2 GLP-1 Peptide Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for GLP-1 Peptide Drugs by Country/Region, 2019, 2023 & 2030
2.2 GLP-1 Peptide Drugs Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 GLP-1 Peptide Drugs Market Size by Type
2.3.1 GLP-1 Peptide Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
2.4 GLP-1 Peptide Drugs Segment by Application
2.4.1 Type 2 Diabetes
2.4.2 Obesity
2.4.3 Others
2.5 GLP-1 Peptide Drugs Market Size by Application
2.5.1 GLP-1 Peptide Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
3 GLP-1 PEPTIDE DRUGS MARKET SIZE BY PLAYER
3.1 GLP-1 Peptide Drugs Market Size Market Share by Player
3.1.1 Global GLP-1 Peptide Drugs Revenue by Player (2019-2024)
3.1.2 Global GLP-1 Peptide Drugs Revenue Market Share by Player (2019-2024)
3.2 Global GLP-1 Peptide Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GLP-1 PEPTIDE DRUGS BY REGION
4.1 GLP-1 Peptide Drugs Market Size by Region (2019-2024)
4.2 Global GLP-1 Peptide Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas GLP-1 Peptide Drugs Market Size Growth (2019-2024)
4.4 APAC GLP-1 Peptide Drugs Market Size Growth (2019-2024)
4.5 Europe GLP-1 Peptide Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa GLP-1 Peptide Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas GLP-1 Peptide Drugs Market Size by Country (2019-2024)
5.2 Americas GLP-1 Peptide Drugs Market Size by Type (2019-2024)
5.3 Americas GLP-1 Peptide Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Peptide Drugs Market Size by Region (2019-2024)
6.2 APAC GLP-1 Peptide Drugs Market Size by Type (2019-2024)
6.3 APAC GLP-1 Peptide Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe GLP-1 Peptide Drugs Market Size by Country (2019-2024)
7.2 Europe GLP-1 Peptide Drugs Market Size by Type (2019-2024)
7.3 Europe GLP-1 Peptide Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Peptide Drugs by Region (2019-2024)
8.2 Middle East & Africa GLP-1 Peptide Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa GLP-1 Peptide Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GLP-1 PEPTIDE DRUGS MARKET FORECAST
10.1 Global GLP-1 Peptide Drugs Forecast by Region (2025-2030)
10.1.1 Global GLP-1 Peptide Drugs Forecast by Region (2025-2030)
10.1.2 Americas GLP-1 Peptide Drugs Forecast
10.1.3 APAC GLP-1 Peptide Drugs Forecast
10.1.4 Europe GLP-1 Peptide Drugs Forecast
10.1.5 Middle East & Africa GLP-1 Peptide Drugs Forecast
10.2 Americas GLP-1 Peptide Drugs Forecast by Country (2025-2030)
10.2.1 United States Market GLP-1 Peptide Drugs Forecast
10.2.2 Canada Market GLP-1 Peptide Drugs Forecast
10.2.3 Mexico Market GLP-1 Peptide Drugs Forecast
10.2.4 Brazil Market GLP-1 Peptide Drugs Forecast
10.3 APAC GLP-1 Peptide Drugs Forecast by Region (2025-2030)
10.3.1 China GLP-1 Peptide Drugs Market Forecast
10.3.2 Japan Market GLP-1 Peptide Drugs Forecast
10.3.3 Korea Market GLP-1 Peptide Drugs Forecast
10.3.4 Southeast Asia Market GLP-1 Peptide Drugs Forecast
10.3.5 India Market GLP-1 Peptide Drugs Forecast
10.3.6 Australia Market GLP-1 Peptide Drugs Forecast
10.4 Europe GLP-1 Peptide Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market GLP-1 Peptide Drugs Forecast
10.4.2 France Market GLP-1 Peptide Drugs Forecast
10.4.3 UK Market GLP-1 Peptide Drugs Forecast
10.4.4 Italy Market GLP-1 Peptide Drugs Forecast
10.4.5 Russia Market GLP-1 Peptide Drugs Forecast
10.5 Middle East & Africa GLP-1 Peptide Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market GLP-1 Peptide Drugs Forecast
10.5.2 South Africa Market GLP-1 Peptide Drugs Forecast
10.5.3 Israel Market GLP-1 Peptide Drugs Forecast
10.5.4 Turkey Market GLP-1 Peptide Drugs Forecast
10.6 Global GLP-1 Peptide Drugs Forecast by Type (2025-2030)
10.7 Global GLP-1 Peptide Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market GLP-1 Peptide Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca GLP-1 Peptide Drugs Product Offered
11.1.3 AstraZeneca GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk GLP-1 Peptide Drugs Product Offered
11.2.3 Novo Nordisk GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi GLP-1 Peptide Drugs Product Offered
11.3.3 Sanofi GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 GSK
11.4.1 GSK Company Information
11.4.2 GSK GLP-1 Peptide Drugs Product Offered
11.4.3 GSK GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GSK Main Business Overview
11.4.5 GSK Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly GLP-1 Peptide Drugs Product Offered
11.5.3 Eli Lilly GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Benemae Pharmaceutical
11.6.1 Benemae Pharmaceutical Company Information
11.6.2 Benemae Pharmaceutical GLP-1 Peptide Drugs Product Offered
11.6.3 Benemae Pharmaceutical GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Benemae Pharmaceutical Main Business Overview
11.6.5 Benemae Pharmaceutical Latest Developments
11.7 Hansoh Pharmaceutical
11.7.1 Hansoh Pharmaceutical Company Information
11.7.2 Hansoh Pharmaceutical GLP-1 Peptide Drugs Product Offered
11.7.3 Hansoh Pharmaceutical GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hansoh Pharmaceutical Main Business Overview
11.7.5 Hansoh Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Peptide Drugs Market Size 2019-2030
2.1.2 GLP-1 Peptide Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for GLP-1 Peptide Drugs by Country/Region, 2019, 2023 & 2030
2.2 GLP-1 Peptide Drugs Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 GLP-1 Peptide Drugs Market Size by Type
2.3.1 GLP-1 Peptide Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
2.4 GLP-1 Peptide Drugs Segment by Application
2.4.1 Type 2 Diabetes
2.4.2 Obesity
2.4.3 Others
2.5 GLP-1 Peptide Drugs Market Size by Application
2.5.1 GLP-1 Peptide Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
3 GLP-1 PEPTIDE DRUGS MARKET SIZE BY PLAYER
3.1 GLP-1 Peptide Drugs Market Size Market Share by Player
3.1.1 Global GLP-1 Peptide Drugs Revenue by Player (2019-2024)
3.1.2 Global GLP-1 Peptide Drugs Revenue Market Share by Player (2019-2024)
3.2 Global GLP-1 Peptide Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GLP-1 PEPTIDE DRUGS BY REGION
4.1 GLP-1 Peptide Drugs Market Size by Region (2019-2024)
4.2 Global GLP-1 Peptide Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas GLP-1 Peptide Drugs Market Size Growth (2019-2024)
4.4 APAC GLP-1 Peptide Drugs Market Size Growth (2019-2024)
4.5 Europe GLP-1 Peptide Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa GLP-1 Peptide Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas GLP-1 Peptide Drugs Market Size by Country (2019-2024)
5.2 Americas GLP-1 Peptide Drugs Market Size by Type (2019-2024)
5.3 Americas GLP-1 Peptide Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Peptide Drugs Market Size by Region (2019-2024)
6.2 APAC GLP-1 Peptide Drugs Market Size by Type (2019-2024)
6.3 APAC GLP-1 Peptide Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe GLP-1 Peptide Drugs Market Size by Country (2019-2024)
7.2 Europe GLP-1 Peptide Drugs Market Size by Type (2019-2024)
7.3 Europe GLP-1 Peptide Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Peptide Drugs by Region (2019-2024)
8.2 Middle East & Africa GLP-1 Peptide Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa GLP-1 Peptide Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GLP-1 PEPTIDE DRUGS MARKET FORECAST
10.1 Global GLP-1 Peptide Drugs Forecast by Region (2025-2030)
10.1.1 Global GLP-1 Peptide Drugs Forecast by Region (2025-2030)
10.1.2 Americas GLP-1 Peptide Drugs Forecast
10.1.3 APAC GLP-1 Peptide Drugs Forecast
10.1.4 Europe GLP-1 Peptide Drugs Forecast
10.1.5 Middle East & Africa GLP-1 Peptide Drugs Forecast
10.2 Americas GLP-1 Peptide Drugs Forecast by Country (2025-2030)
10.2.1 United States Market GLP-1 Peptide Drugs Forecast
10.2.2 Canada Market GLP-1 Peptide Drugs Forecast
10.2.3 Mexico Market GLP-1 Peptide Drugs Forecast
10.2.4 Brazil Market GLP-1 Peptide Drugs Forecast
10.3 APAC GLP-1 Peptide Drugs Forecast by Region (2025-2030)
10.3.1 China GLP-1 Peptide Drugs Market Forecast
10.3.2 Japan Market GLP-1 Peptide Drugs Forecast
10.3.3 Korea Market GLP-1 Peptide Drugs Forecast
10.3.4 Southeast Asia Market GLP-1 Peptide Drugs Forecast
10.3.5 India Market GLP-1 Peptide Drugs Forecast
10.3.6 Australia Market GLP-1 Peptide Drugs Forecast
10.4 Europe GLP-1 Peptide Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market GLP-1 Peptide Drugs Forecast
10.4.2 France Market GLP-1 Peptide Drugs Forecast
10.4.3 UK Market GLP-1 Peptide Drugs Forecast
10.4.4 Italy Market GLP-1 Peptide Drugs Forecast
10.4.5 Russia Market GLP-1 Peptide Drugs Forecast
10.5 Middle East & Africa GLP-1 Peptide Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market GLP-1 Peptide Drugs Forecast
10.5.2 South Africa Market GLP-1 Peptide Drugs Forecast
10.5.3 Israel Market GLP-1 Peptide Drugs Forecast
10.5.4 Turkey Market GLP-1 Peptide Drugs Forecast
10.6 Global GLP-1 Peptide Drugs Forecast by Type (2025-2030)
10.7 Global GLP-1 Peptide Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market GLP-1 Peptide Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca GLP-1 Peptide Drugs Product Offered
11.1.3 AstraZeneca GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk GLP-1 Peptide Drugs Product Offered
11.2.3 Novo Nordisk GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi GLP-1 Peptide Drugs Product Offered
11.3.3 Sanofi GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 GSK
11.4.1 GSK Company Information
11.4.2 GSK GLP-1 Peptide Drugs Product Offered
11.4.3 GSK GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GSK Main Business Overview
11.4.5 GSK Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly GLP-1 Peptide Drugs Product Offered
11.5.3 Eli Lilly GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Benemae Pharmaceutical
11.6.1 Benemae Pharmaceutical Company Information
11.6.2 Benemae Pharmaceutical GLP-1 Peptide Drugs Product Offered
11.6.3 Benemae Pharmaceutical GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Benemae Pharmaceutical Main Business Overview
11.6.5 Benemae Pharmaceutical Latest Developments
11.7 Hansoh Pharmaceutical
11.7.1 Hansoh Pharmaceutical Company Information
11.7.2 Hansoh Pharmaceutical GLP-1 Peptide Drugs Product Offered
11.7.3 Hansoh Pharmaceutical GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hansoh Pharmaceutical Main Business Overview
11.7.5 Hansoh Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 Peptide Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. GLP-1 Peptide Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. GLP-1 Peptide Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 7. Global GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Table 8. GLP-1 Peptide Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 10. Global GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Table 11. Global GLP-1 Peptide Drugs Revenue by Player (2019-2024) & ($ millions)
Table 12. Global GLP-1 Peptide Drugs Revenue Market Share by Player (2019-2024)
Table 13. GLP-1 Peptide Drugs Key Players Head office and Products Offered
Table 14. GLP-1 Peptide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global GLP-1 Peptide Drugs Market Size by Region (2019-2024) & ($ millions)
Table 18. Global GLP-1 Peptide Drugs Market Size Market Share by Region (2019-2024)
Table 19. Global GLP-1 Peptide Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global GLP-1 Peptide Drugs Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas GLP-1 Peptide Drugs Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas GLP-1 Peptide Drugs Market Size Market Share by Country (2019-2024)
Table 23. Americas GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Table 25. Americas GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Table 27. APAC GLP-1 Peptide Drugs Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC GLP-1 Peptide Drugs Market Size Market Share by Region (2019-2024)
Table 29. APAC GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe GLP-1 Peptide Drugs Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe GLP-1 Peptide Drugs Market Size Market Share by Country (2019-2024)
Table 33. Europe GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa GLP-1 Peptide Drugs Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of GLP-1 Peptide Drugs
Table 39. Key Market Challenges & Risks of GLP-1 Peptide Drugs
Table 40. Key Industry Trends of GLP-1 Peptide Drugs
Table 41. Global GLP-1 Peptide Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global GLP-1 Peptide Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global GLP-1 Peptide Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global GLP-1 Peptide Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. AstraZeneca Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 46. AstraZeneca GLP-1 Peptide Drugs Product Offered
Table 47. AstraZeneca GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. AstraZeneca Main Business
Table 49. AstraZeneca Latest Developments
Table 50. Novo Nordisk Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 51. Novo Nordisk GLP-1 Peptide Drugs Product Offered
Table 52. Novo Nordisk GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Novo Nordisk Main Business
Table 54. Novo Nordisk Latest Developments
Table 55. Sanofi Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 56. Sanofi GLP-1 Peptide Drugs Product Offered
Table 57. Sanofi GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Sanofi Main Business
Table 59. Sanofi Latest Developments
Table 60. GSK Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 61. GSK GLP-1 Peptide Drugs Product Offered
Table 62. GSK GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GSK Main Business
Table 64. GSK Latest Developments
Table 65. Eli Lilly Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 66. Eli Lilly GLP-1 Peptide Drugs Product Offered
Table 67. Eli Lilly GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Eli Lilly Main Business
Table 69. Eli Lilly Latest Developments
Table 70. Benemae Pharmaceutical Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 71. Benemae Pharmaceutical GLP-1 Peptide Drugs Product Offered
Table 72. Benemae Pharmaceutical GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Benemae Pharmaceutical Main Business
Table 74. Benemae Pharmaceutical Latest Developments
Table 75. Hansoh Pharmaceutical Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 76. Hansoh Pharmaceutical GLP-1 Peptide Drugs Product Offered
Table 77. Hansoh Pharmaceutical GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Hansoh Pharmaceutical Main Business
Table 79. Hansoh Pharmaceutical Latest Developments
Table 1. GLP-1 Peptide Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. GLP-1 Peptide Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. GLP-1 Peptide Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 7. Global GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Table 8. GLP-1 Peptide Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 10. Global GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Table 11. Global GLP-1 Peptide Drugs Revenue by Player (2019-2024) & ($ millions)
Table 12. Global GLP-1 Peptide Drugs Revenue Market Share by Player (2019-2024)
Table 13. GLP-1 Peptide Drugs Key Players Head office and Products Offered
Table 14. GLP-1 Peptide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global GLP-1 Peptide Drugs Market Size by Region (2019-2024) & ($ millions)
Table 18. Global GLP-1 Peptide Drugs Market Size Market Share by Region (2019-2024)
Table 19. Global GLP-1 Peptide Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global GLP-1 Peptide Drugs Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas GLP-1 Peptide Drugs Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas GLP-1 Peptide Drugs Market Size Market Share by Country (2019-2024)
Table 23. Americas GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Table 25. Americas GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Table 27. APAC GLP-1 Peptide Drugs Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC GLP-1 Peptide Drugs Market Size Market Share by Region (2019-2024)
Table 29. APAC GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe GLP-1 Peptide Drugs Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe GLP-1 Peptide Drugs Market Size Market Share by Country (2019-2024)
Table 33. Europe GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa GLP-1 Peptide Drugs Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa GLP-1 Peptide Drugs Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa GLP-1 Peptide Drugs Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of GLP-1 Peptide Drugs
Table 39. Key Market Challenges & Risks of GLP-1 Peptide Drugs
Table 40. Key Industry Trends of GLP-1 Peptide Drugs
Table 41. Global GLP-1 Peptide Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global GLP-1 Peptide Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global GLP-1 Peptide Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global GLP-1 Peptide Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. AstraZeneca Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 46. AstraZeneca GLP-1 Peptide Drugs Product Offered
Table 47. AstraZeneca GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. AstraZeneca Main Business
Table 49. AstraZeneca Latest Developments
Table 50. Novo Nordisk Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 51. Novo Nordisk GLP-1 Peptide Drugs Product Offered
Table 52. Novo Nordisk GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Novo Nordisk Main Business
Table 54. Novo Nordisk Latest Developments
Table 55. Sanofi Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 56. Sanofi GLP-1 Peptide Drugs Product Offered
Table 57. Sanofi GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Sanofi Main Business
Table 59. Sanofi Latest Developments
Table 60. GSK Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 61. GSK GLP-1 Peptide Drugs Product Offered
Table 62. GSK GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GSK Main Business
Table 64. GSK Latest Developments
Table 65. Eli Lilly Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 66. Eli Lilly GLP-1 Peptide Drugs Product Offered
Table 67. Eli Lilly GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Eli Lilly Main Business
Table 69. Eli Lilly Latest Developments
Table 70. Benemae Pharmaceutical Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 71. Benemae Pharmaceutical GLP-1 Peptide Drugs Product Offered
Table 72. Benemae Pharmaceutical GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Benemae Pharmaceutical Main Business
Table 74. Benemae Pharmaceutical Latest Developments
Table 75. Hansoh Pharmaceutical Details, Company Type, GLP-1 Peptide Drugs Area Served and Its Competitors
Table 76. Hansoh Pharmaceutical GLP-1 Peptide Drugs Product Offered
Table 77. Hansoh Pharmaceutical GLP-1 Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Hansoh Pharmaceutical Main Business
Table 79. Hansoh Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. GLP-1 Peptide Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GLP-1 Peptide Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. GLP-1 Peptide Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. GLP-1 Peptide Drugs Sales Market Share by Country/Region (2023)
Figure 8. GLP-1 Peptide Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global GLP-1 Peptide Drugs Market Size Market Share by Type in 2023
Figure 10. GLP-1 Peptide Drugs in Type 2 Diabetes
Figure 11. Global GLP-1 Peptide Drugs Market: Type 2 Diabetes (2019-2024) & ($ millions)
Figure 12. GLP-1 Peptide Drugs in Obesity
Figure 13. Global GLP-1 Peptide Drugs Market: Obesity (2019-2024) & ($ millions)
Figure 14. GLP-1 Peptide Drugs in Others
Figure 15. Global GLP-1 Peptide Drugs Market: Others (2019-2024) & ($ millions)
Figure 16. Global GLP-1 Peptide Drugs Market Size Market Share by Application in 2023
Figure 17. Global GLP-1 Peptide Drugs Revenue Market Share by Player in 2023
Figure 18. Global GLP-1 Peptide Drugs Market Size Market Share by Region (2019-2024)
Figure 19. Americas GLP-1 Peptide Drugs Market Size 2019-2024 ($ millions)
Figure 20. APAC GLP-1 Peptide Drugs Market Size 2019-2024 ($ millions)
Figure 21. Europe GLP-1 Peptide Drugs Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa GLP-1 Peptide Drugs Market Size 2019-2024 ($ millions)
Figure 23. Americas GLP-1 Peptide Drugs Value Market Share by Country in 2023
Figure 24. United States GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC GLP-1 Peptide Drugs Market Size Market Share by Region in 2023
Figure 29. APAC GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Figure 30. APAC GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Figure 31. China GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. India GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe GLP-1 Peptide Drugs Market Size Market Share by Country in 2023
Figure 38. Europe GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. France GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. UK GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa GLP-1 Peptide Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 54. APAC GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 55. Europe GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 57. United States GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 58. Canada GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 59. Mexico GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 60. Brazil GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 61. China GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 62. Japan GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 63. Korea GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 65. India GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 66. Australia GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 67. Germany GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 68. France GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 69. UK GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 70. Italy GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 71. Russia GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 72. Egypt GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 73. South Africa GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 74. Israel GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 75. Turkey GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 77. Global GLP-1 Peptide Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global GLP-1 Peptide Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. GLP-1 Peptide Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GLP-1 Peptide Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. GLP-1 Peptide Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. GLP-1 Peptide Drugs Sales Market Share by Country/Region (2023)
Figure 8. GLP-1 Peptide Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global GLP-1 Peptide Drugs Market Size Market Share by Type in 2023
Figure 10. GLP-1 Peptide Drugs in Type 2 Diabetes
Figure 11. Global GLP-1 Peptide Drugs Market: Type 2 Diabetes (2019-2024) & ($ millions)
Figure 12. GLP-1 Peptide Drugs in Obesity
Figure 13. Global GLP-1 Peptide Drugs Market: Obesity (2019-2024) & ($ millions)
Figure 14. GLP-1 Peptide Drugs in Others
Figure 15. Global GLP-1 Peptide Drugs Market: Others (2019-2024) & ($ millions)
Figure 16. Global GLP-1 Peptide Drugs Market Size Market Share by Application in 2023
Figure 17. Global GLP-1 Peptide Drugs Revenue Market Share by Player in 2023
Figure 18. Global GLP-1 Peptide Drugs Market Size Market Share by Region (2019-2024)
Figure 19. Americas GLP-1 Peptide Drugs Market Size 2019-2024 ($ millions)
Figure 20. APAC GLP-1 Peptide Drugs Market Size 2019-2024 ($ millions)
Figure 21. Europe GLP-1 Peptide Drugs Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa GLP-1 Peptide Drugs Market Size 2019-2024 ($ millions)
Figure 23. Americas GLP-1 Peptide Drugs Value Market Share by Country in 2023
Figure 24. United States GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC GLP-1 Peptide Drugs Market Size Market Share by Region in 2023
Figure 29. APAC GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Figure 30. APAC GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Figure 31. China GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. India GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe GLP-1 Peptide Drugs Market Size Market Share by Country in 2023
Figure 38. Europe GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. France GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. UK GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa GLP-1 Peptide Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa GLP-1 Peptide Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa GLP-1 Peptide Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries GLP-1 Peptide Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 54. APAC GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 55. Europe GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 57. United States GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 58. Canada GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 59. Mexico GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 60. Brazil GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 61. China GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 62. Japan GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 63. Korea GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 65. India GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 66. Australia GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 67. Germany GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 68. France GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 69. UK GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 70. Italy GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 71. Russia GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 72. Egypt GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 73. South Africa GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 74. Israel GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 75. Turkey GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries GLP-1 Peptide Drugs Market Size 2025-2030 ($ millions)
Figure 77. Global GLP-1 Peptide Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global GLP-1 Peptide Drugs Market Size Market Share Forecast by Application (2025-2030)
